Impact of rosiglitazone safety alerts on oral antidiabetic sales trends: a country-wide study in Portugal

18/03/2016
01/04/2024
EU PAS number:
EUPAS12872
Study
Finalised
Documents
Study protocol
Study results
Study report
Other information
Publications